84
Participants
Start Date
November 30, 2016
Primary Completion Date
March 31, 2019
Study Completion Date
September 30, 2019
Ropivacaine
Ketorolac
Placebo
Duke University Hospital, Durham
Lead Sponsor
Duke University
OTHER